Literature DB >> 16865589

Surgery and hematogenous dissemination: comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats.

Dolores C García-Olmo1, Lydia Gutiérrez-González, Julia Samos, María G Picazo, Manuel Atiénzar, Damián García-Olmo.   

Abstract

BACKGROUND: To examine the effects of the surgical manipulation of tumors on the hematogenous dissemination of tumors, we compared rates of detection of tumor-derived DNA in the buffy coat and in plasma from tumor-bearing rats before and after tumor resection.
METHODS: We injected DHD/K12-PROb cells subcutaneously into BD-IX rats. Three weeks later, we removed the tumors surgically. Group PERI was sacrificed 3 hours after surgery, group POST-2 was sacrificed 2 weeks later, group POST-4 was sacrificed another 2 weeks later, and group POST-LONG was sacrificed when rats were close to death. In group PERI, four perioperative blood samples were taken. In the other groups, only one blood sample was taken per rat, immediately before euthanasia. We used polymerase chain reaction to detect tumor-derived DNA in buffy-coat, plasma, and lung samples.
RESULTS: In group PERI, tumor DNA in plasma was more frequent than circulating tumor cells at all perioperative time points. The difference was statistically significant 3 hours after surgery (P = .035). In group POST-2, there was no detectable metastasis or tumor DNA in blood samples. There were lymphatic and lung metastases in most animals in group POST-4 and in all animals in group POST-LONG. In the last two groups, the frequencies of tumor DNA in the buffy coat and in plasma were similar.
CONCLUSIONS: In our animal model, the hematogenous dissemination of tumors due to surgery seemed to be more closely related to tumor-derived cell-free DNA than to circulating tumor cells. In addition, the surgical resection of primary tumors did not inhibit the development of metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865589     DOI: 10.1245/ASO.2006.05.032

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer.

Authors:  Zhen-yu Zhang; Zhen-ling Dai; Xiao-wei Yin; Shu-heng Li; Shu-ping Li; Hai-yan Ge
Journal:  BMC Cancer       Date:  2014-10-21       Impact factor: 4.430

Review 2.  Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory.

Authors:  Ana García-Casas; Dolores C García-Olmo; Damián García-Olmo
Journal:  World J Clin Oncol       Date:  2017-10-10

Review 3.  Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.

Authors:  Feifei Cheng; Li Su; Cheng Qian
Journal:  Oncotarget       Date:  2016-07-26

4.  Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.

Authors:  Li-Han Lin; Kuo-Wei Chang; Shou-Yen Kao; Hui-Wen Cheng; Chung-Ji Liu
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

5.  Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid.

Authors:  Michael D White; Robert H Klein; Brian Shaw; Albert Kim; Megha Subramanian; Joana L Mora; Anita Giobbie-Hurder; Deepika Nagabhushan; Aarushi Jain; Mohini Singh; Benjamin M Kuter; Naema Nayyar; Mia S Bertalan; Jackson H Stocking; Samuel C Markson; Matthew Lastrapes; Christopher Alvarez-Breckenridge; Daniel P Cahill; Gregory Gydush; Justin Rhoades; Denisse Rotem; Viktor A Adalsteinsson; Maura Mahar; Alexander Kaplan; Kevin Oh; Ryan J Sullivan; Elizabeth Gerstner; Scott L Carter; Priscilla K Brastianos
Journal:  JAMA Netw Open       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.